Seeking Alpha

  Cytokinetics, Incorporated - NASDAQ

10/21/2014, 12:33 AM ET
  • The Scientist | Send Message 8 Jan 2013

    Wall Street finally giving $CYTK the attention it deserves. No other biotech has anything close to Omecamtiv and Tirasemtiv in development.
      CYTK vs. ETF Alternatives
      Company Description
      Cytokinetics Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States